Grønbæk H - Search Results

1

Hepatic macrophage activation predicts clinical decompensation in chronic liver disease.

Rode A, Nicoll A, Møller HJ, Lim L, Angus PW, Kronborg I, Arachchi N, Gorelik A, Liew D, Kazankov K, Vilstrup H, Grønbæk H. Rode A, et al. Among authors: gronbaek h. Gut. 2013 Aug;62(8):1231-2. doi: 10.1136/gutjnl-2012-304135. Epub 2013 Feb 26. Gut. 2013. PMID: 23442440 No abstract available.

2

Soluble CD163: a marker molecule for monocyte/macrophage activity in disease.

Møller HJ, Aerts H, Grønbaek H, Peterslund NA, Hyltoft Petersen P, Hornung N, Rejnmark L, Jabbarpour E, Moestrup SK. Møller HJ, et al. Among authors: gronbaek h. Scand J Clin Lab Invest Suppl. 2002;237:29-33. doi: 10.1080/003655102762377466. Scand J Clin Lab Invest Suppl. 2002. PMID: 12570164

3

[Nonalcoholic steatohepatitis--a "new" hepatic disease].

Grønbaek H, Eivindson MV, Hamilton-Dutoit S, Vilstrup H. Grønbaek H, et al. Ugeskr Laeger. 2003 Mar 10;165(11):1115-8. Ugeskr Laeger. 2003. PMID: 12677985 Review. Danish.

4

[Pharmacologic treatment or endoscopic sclerotherapy as primary intervention for bleeding varices in cirrhotic patients].

Grønbaek H, Dahlerup JF, Vilstrup H. Grønbaek H, et al. Ugeskr Laeger. 2003 Mar 10;165(11):1127-30. Ugeskr Laeger. 2003. PMID: 12677989 Danish. No abstract available.

5

Soluble CD163 from activated macrophages predicts mortality in acute liver failure.

Møller HJ, Grønbaek H, Schiødt FV, Holland-Fischer P, Schilsky M, Munoz S, Hassanein T, Lee WM; U.S. Acute Liver Failure Study Group. Møller HJ, et al. Among authors: gronbaek h. J Hepatol. 2007 Nov;47(5):671-6. doi: 10.1016/j.jhep.2007.05.014. Epub 2007 Jun 21. J Hepatol. 2007. PMID: 17629586 Free PMC article.

6

[Treatment of bleeding esophageal varices. A 20-year old research-based successful history--how does it continue?].

Grønbaek H, Vilstrup H. Grønbaek H, et al. Ugeskr Laeger. 2007 Aug 20;169(34):2751. Ugeskr Laeger. 2007. PMID: 17878008 Danish. No abstract available.

7

[Therapy of continuously bleeding oesophageal varices by self expanding metal stents].

Dahlerup JF, Kruse A, Grønbaek H, Vilstrup H. Dahlerup JF, et al. Among authors: gronbaek h. Ugeskr Laeger. 2007 Aug 20;169(34):2784-5. Ugeskr Laeger. 2007. PMID: 17878018 Danish.

8

Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes.

Grønbaek H, Thomsen KL, Rungby J, Schmitz O, Vilstrup H. Grønbaek H, et al. Expert Rev Gastroenterol Hepatol. 2008 Oct;2(5):705-11. doi: 10.1586/17474124.2.5.705. Expert Rev Gastroenterol Hepatol. 2008. PMID: 19072347 Review.

9

Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study.

Søgaard KK, Horváth-Puhó E, Grønbaek H, Jepsen P, Vilstrup H, Sørensen HT. Søgaard KK, et al. Among authors: gronbaek h. Am J Gastroenterol. 2009 Jan;104(1):96-101. doi: 10.1038/ajg.2008.34. Am J Gastroenterol. 2009. PMID: 19098856

10

Age-dependency of galactose elimination capacity in healthy children and children with chronic liver disease.

Lange A, Grønbæk H, Vilstrup H, Keiding S. Lange A, et al. Among authors: gronbaek h. Scand J Gastroenterol. 2011 Feb;46(2):197-200. doi: 10.3109/00365521.2010.522727. Epub 2010 Nov 1. Scand J Gastroenterol. 2011. PMID: 21034348 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

393 results

Search Page

Filters